Funded Tech Companies

Araris Biotech

Araris Biotech is a biopharmaceutical company, based in Zurich. Financial backing was provided by private investors, VI Partners and btov Partners.

Company Overview

Contact Information

Company Background Information

Overview

Araris Biotech AG, a spin-off company from the Paul Scherrer Institute (PSI) and ETH Zurich, is pioneering the development of a novel, proprietary antibody-drug conjugate (ADC)-linker technology. Our linker platform enables payload attachment to 'off-the-shelf' antibodies in one step without needing to re-engineer or reduce antibodies, resulting in highly homogenous, stable and potent ADC therapies.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

5/5/2023

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Philipp Spycher

        

Co-Founder

Isabella Toller

        

Company Investors

• VI Partners
• btov Partners
• 4BIO Capital
• Pureos Bioventures
• Follicular Lymphoma Innovation (Sophie Allauzen)
• Wille AG (Damir Illich)
• Schroders Capital
• Redalpine Venture

Browse more funded tech companies:

Arantech | Aras

Share this article

About Our VC & M&A Database

This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary